Dartmouth Health Continuing Education for Professionals Home, The Fourth Annual Dartmouth-Hitchcock Nursing Research Symposium - Keynote: Bedside to Bench to Bedside: Nursing Research to Inform Practice (Part 1 of 3), 5/3/2021 8:00:00 AM - 5/3/2024 9:00:00 AM, Many nurses are unsure how to respond when asked to discuss the difference between evidence-based nursing practice (EBP), nursing research, and quality improvement (QI). All of these processes, when done well, result in new knowledge generation or knowledge synthesis. Each process has unique features and essential requirements, and all have the potential to inform and improve nursing care and nursing practice. Evidence-based practice, nursing research and quality improvement all start with some form of a question, and many factors enter into a decision to choose one discovery process over another to answer the question. Join us as we learn how to determine whether an evidence-based practice, research, or quality improvement process is best suited to explore a question that YOU might have about your practice.
This year, our keynote speaker is former Norris Cotton Cancer Center advanced practice nurse and scientist Ellen Lavoie Smith, Ph.D., MSN, RN, AOCN®, FAAN. Dr. Smith will share her professional development path as well as highlight her contributions to nursing science in the field of oncology nursing. We look forward to hosting our additional presenters at this conference, all of whom are current and former DH nurses.
Presenter
Ellen M. Lavoie Smith, Ph.D., MSN, AOCN, FAAN
Ellen M. Lavoie Smith, PhD, MSN, AOCN, FAAN – Dr. Smith is a tenured Professor at the University of Michigan School of Nursing. She has extensive experience as an educator at the University level and Director an academic program: the PhD program at the school. Ellen has over 30 years of experience as an oncology nurse clinician, administrator, educator, and researcher. She has lectured extensively at local, regional, national, and international venues regarding topics relevant to my clinical experience and research program. Dr. Smith has published 84 peer-reviewed papers, multiple book chapters, and have received research funding from the NIH and other sources, all of which are relevant to the educational activity that she will provide as a keynote speaker at DHMC.
Learning Outcome(s)
At the end of this learning activity, (at least 75% of) participants will be able to discuss how nursing research informs practice at the point of care.
Disclosure
The activity director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content have reported NO financial interest or relationship* with various companies. There were no individuals in a position to control the content that refused to disclose.
*A “financial interest or relationship" refers to an equity position, receipt of royalties, consultantship, funding by a research grant, receiving honoraria for educational services elsewhere, or to any other relationship to a company that provides sufficient reason for disclosure, in keeping with the spirit of the stated policy.
Bibliographic Sources
Argyriou, A. A. et al (2013). Voltage-gated sodium channel polymorphisms play a pivotal role in the development of oxaliplatin-induced peripheral neurotoxicity: Results from a prospective multicenter study. Cancer, 119(19), 3570–3577. https://doi.org/10.1002/cncr.28234.
Argyriou, A. A. et al (2014). Chemotherapy-induced peripheral neuropathy in adults: A comprehensive update of the literature. Cancer Management and Research, 6, 135–147. https://doi.org/10.2147/CMAR.S44261.
Beijers, A. J. M. et al (2014). Chemotherapy-induced peripheral neuropathy and impact on quality of life six months after treatment with taxanes and platinum derivatives. The Journal of Community and Supportive Oncology, 12(11), 401–406. https://doi.org/10.12788/jcso.0086.
Bingel, U., & Tracey, I. (2008). Imaging CNS modulation of pain in humans. Physiology, 23(6), 371–380. https://doi.org/10.1152/physiol.00024.2008.
Briani, C., et al (2014). Long-term course of oxaliplatin-induced polyneuropathy: A prospective 2-year follow-up study. Journal of the Peripheral Nervous System?: JPNS, 19(4), 299–306. https://doi.org/10.1111/jns.12097.
Crisson, J. E., & Keefe, F. J. (1988). The relationship of locus of control to pain coping strategies and psychological distress in chronic pain patients. Pain, 35(2), 147–154. https://doi.org/10.1016/0304-3959(88)90222-9.
Davis, L. L., Kroenke, K., Monahan, P., Kean, J., & Stump, T. E. (2016). The SPADE symptom cluster in primary care patients with chronic pain. The Clinical Journal of Pain, 32(5), 388–393. https://doi.org/10.1097/AJP.0000000000000286.
Dorsey, S. G. et al (2019). The National Cancer Institute Clinical Trials Planning Meeting for Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy. J Natl Cancer Inst, 111(6), 531–537. https://doi.org/10.1093/jnci/djz011.
Edwards, R. R., Bingham 3rd, C. O., Bathon, J., & Haythornthwaite, J. A. (2006). Catastrophizing and pain in arthritis, fibromyalgia, and other rheumatic diseases. Arthritis & Rheumatism, 55(2), 325–332. https://doi.org/10.1002/art.21865.
Flor, H., & Turk, D. C. (2015). Chronic Pain: An Integrated Biobehavioral Approach. Wolters Kluwer Health. https://books.google.com/books?id=TqPACQAAQBAJ.
Hershman, D. L. et al (2014). Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline. Journal of Clinical Oncology, 32(18), 1941–1967. https://doi.org/10.1200/JCO.2013.54.0914.
?Humphreys, J., Cooper, B. A., & Miaskowski, C. (2010). Differences in depression, posttraumatic stress disorder, and lifetime trauma exposure in formerly abused women with mild versus moderate to severe chronic pain. Journal of Interpersonal Violence, 25(12), 2316–2338. http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=medl&AN=20129915.
Kanzawa-lee, G. A., Harte, S. E., Bridges, C. M., Brummett, C., Clauw, D. J., Williams, D. A., Knoerl, R., & Smith, E. M. L. (2018). Pressure Pain Phenotypes in Women Before Breast Cancer Treatment. Oncology Nursing Forum, 45(4), 1–13. https://doi.org/10.1188/18.ONF.xxx-xxx.
Kanzawa-Lee, G. A. et al (2019). Mechanisms, predictors, and challenges in assessing and managing painful chemotherapy-induced peripheral neuropathy. Seminars in Oncology Nursing, 35(3), 253–260. https://doi.org/10.1016/j.soncn.2019.04.006.
Kanzawa-Lee, G. A., Knoerl, R., Williams, D. A., Clauw, D. J., Bridges, C. M., Harte, S. E., Kolarik, E., Houghtby, J., & Lavoie Smith, E. M. (2020). Childhood trauma predicts cancer treatment–related pain in breast cancer survivors. Cancer Nursing, 43(4), E207–E216. https://doi.org/10.1097/NCC.0000000000000687
Knoerl, R., Chornoby, Z., & Smith, E. M. L. (2018). Estimating the Frequency, Severity, and Clustering of SPADE Symptoms in Chronic Painful Chemotherapy-Induced Peripheral Neuropathy. Pain Management Nursing, 19(4), 354–365. https://doi.org/10.1016/j.pmn.2018.01.001.
Latremoliere, A., & Woolf, C. J. (2009). Central Sensitization: A Generator of Pain Hypersensitivity by Central Neural Plasticity. The Journal of Pain, 10(9), 895–926. https://doi.org/https://doi.org/10.1016/j.jpain.2009.06.012.
Loprinzi, C. L. et al (2020). Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update. Journal of Clinical Oncology?: Official Journal of the American Society of Clinical Oncology, 38(28). https://doi.org/10.1200/JCO.20.01399.
Meltzer-Brody, S., Leserman, J., Zolnoun, D., Steege, J., Green, E., & Teich, A. (2007). Trauma and posttraumatic stress disorder in women with chronic pelvic pain. Obstetrics and Gynecology, 109(4), 902–908. https://doi.org/10.1097/01.AOG.0000258296.35538.88.
Nicol, A. L. et al (2016). The association between a history of lifetime traumatic events and pain severity, physical function, and affective distress in patients with chronic pain. The Journal of Pain, 17(12), 1334–1348. https://doi.org/10.1016/j.jpain.2016.09.003.
Park, S. B. et al (2013). Chemotherapy-Induced Peripheral Neurotoxicity: A Critical Analysis. CA Cancer Journal for Clinicians, 63(6), 419–437. https://doi.org/10.1002/caac.21204.
Seretny, M., Currie, G. L., Sena, E. S., Ramnarine, S., Grant, R., MacLeod, M. R., Colvin, L. A., & Fallon, M. (2014). Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis. Pain, 155(12), 2461–2470. https://doi.org/10.1016/j.pain.2014.09.020.
Smith, E.M.L. et al (2014). Cancer treatment-related neuropathic pain syndromes—epidemiology and treatment: An update. Current Pain and Headache Reports, 18(11). https://doi.org/10.1007/s11916-014-0459-7.
Smith, Ellen M Lavoie, et al (2013). Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy. JAMA, 309(13), 1359–1367.
Spinhoven, P. et al (2004). Catastrophizing and internal pain control as mediators of outcome in the multidisciplinary treatment of chronic low back pain. European Journal of Pain (London, England), 8(3), 211–219. https://doi.org/10.1016/j.ejpain.2003.08.00.
Wang, S.-Y., Calderon, J., & Kuo Wang, G. (2010). Block of neuronal Na+ channels by antidepressant duloxetine in a state-dependent manner. Anesthesiology, 113(3), 655–665. http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=med6&AN=2069387.
This year, our keynote speaker is former Norris Cotton Cancer Center advanced practice nurse and scientist Ellen Lavoie Smith, Ph.D., MSN, RN, AOCN®, FAAN. Dr. Smith will share her professional development path as well as highlight her contributions to nursing science in the field of oncology nursing. We look forward to hosting our additional presenters at this conference, all of whom are current and former DH nurses.
Presenter
Ellen M. Lavoie Smith, Ph.D., MSN, AOCN, FAAN
Ellen M. Lavoie Smith, PhD, MSN, AOCN, FAAN – Dr. Smith is a tenured Professor at the University of Michigan School of Nursing. She has extensive experience as an educator at the University level and Director an academic program: the PhD program at the school. Ellen has over 30 years of experience as an oncology nurse clinician, administrator, educator, and researcher. She has lectured extensively at local, regional, national, and international venues regarding topics relevant to my clinical experience and research program. Dr. Smith has published 84 peer-reviewed papers, multiple book chapters, and have received research funding from the NIH and other sources, all of which are relevant to the educational activity that she will provide as a keynote speaker at DHMC.
Learning Outcome(s)
At the end of this learning activity, (at least 75% of) participants will be able to discuss how nursing research informs practice at the point of care.
Disclosure
The activity director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content have reported NO financial interest or relationship* with various companies. There were no individuals in a position to control the content that refused to disclose.
*A “financial interest or relationship" refers to an equity position, receipt of royalties, consultantship, funding by a research grant, receiving honoraria for educational services elsewhere, or to any other relationship to a company that provides sufficient reason for disclosure, in keeping with the spirit of the stated policy.
Bibliographic Sources
Argyriou, A. A. et al (2013). Voltage-gated sodium channel polymorphisms play a pivotal role in the development of oxaliplatin-induced peripheral neurotoxicity: Results from a prospective multicenter study. Cancer, 119(19), 3570–3577. https://doi.org/10.1002/cncr.28234.
Argyriou, A. A. et al (2014). Chemotherapy-induced peripheral neuropathy in adults: A comprehensive update of the literature. Cancer Management and Research, 6, 135–147. https://doi.org/10.2147/CMAR.S44261.
Beijers, A. J. M. et al (2014). Chemotherapy-induced peripheral neuropathy and impact on quality of life six months after treatment with taxanes and platinum derivatives. The Journal of Community and Supportive Oncology, 12(11), 401–406. https://doi.org/10.12788/jcso.0086.
Bingel, U., & Tracey, I. (2008). Imaging CNS modulation of pain in humans. Physiology, 23(6), 371–380. https://doi.org/10.1152/physiol.00024.2008.
Briani, C., et al (2014). Long-term course of oxaliplatin-induced polyneuropathy: A prospective 2-year follow-up study. Journal of the Peripheral Nervous System?: JPNS, 19(4), 299–306. https://doi.org/10.1111/jns.12097.
Crisson, J. E., & Keefe, F. J. (1988). The relationship of locus of control to pain coping strategies and psychological distress in chronic pain patients. Pain, 35(2), 147–154. https://doi.org/10.1016/0304-3959(88)90222-9.
Davis, L. L., Kroenke, K., Monahan, P., Kean, J., & Stump, T. E. (2016). The SPADE symptom cluster in primary care patients with chronic pain. The Clinical Journal of Pain, 32(5), 388–393. https://doi.org/10.1097/AJP.0000000000000286.
Dorsey, S. G. et al (2019). The National Cancer Institute Clinical Trials Planning Meeting for Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy. J Natl Cancer Inst, 111(6), 531–537. https://doi.org/10.1093/jnci/djz011.
Edwards, R. R., Bingham 3rd, C. O., Bathon, J., & Haythornthwaite, J. A. (2006). Catastrophizing and pain in arthritis, fibromyalgia, and other rheumatic diseases. Arthritis & Rheumatism, 55(2), 325–332. https://doi.org/10.1002/art.21865.
Flor, H., & Turk, D. C. (2015). Chronic Pain: An Integrated Biobehavioral Approach. Wolters Kluwer Health. https://books.google.com/books?id=TqPACQAAQBAJ.
Hershman, D. L. et al (2014). Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline. Journal of Clinical Oncology, 32(18), 1941–1967. https://doi.org/10.1200/JCO.2013.54.0914.
?Humphreys, J., Cooper, B. A., & Miaskowski, C. (2010). Differences in depression, posttraumatic stress disorder, and lifetime trauma exposure in formerly abused women with mild versus moderate to severe chronic pain. Journal of Interpersonal Violence, 25(12), 2316–2338. http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=medl&AN=20129915.
Kanzawa-lee, G. A., Harte, S. E., Bridges, C. M., Brummett, C., Clauw, D. J., Williams, D. A., Knoerl, R., & Smith, E. M. L. (2018). Pressure Pain Phenotypes in Women Before Breast Cancer Treatment. Oncology Nursing Forum, 45(4), 1–13. https://doi.org/10.1188/18.ONF.xxx-xxx.
Kanzawa-Lee, G. A. et al (2019). Mechanisms, predictors, and challenges in assessing and managing painful chemotherapy-induced peripheral neuropathy. Seminars in Oncology Nursing, 35(3), 253–260. https://doi.org/10.1016/j.soncn.2019.04.006.
Kanzawa-Lee, G. A., Knoerl, R., Williams, D. A., Clauw, D. J., Bridges, C. M., Harte, S. E., Kolarik, E., Houghtby, J., & Lavoie Smith, E. M. (2020). Childhood trauma predicts cancer treatment–related pain in breast cancer survivors. Cancer Nursing, 43(4), E207–E216. https://doi.org/10.1097/NCC.0000000000000687
Knoerl, R., Chornoby, Z., & Smith, E. M. L. (2018). Estimating the Frequency, Severity, and Clustering of SPADE Symptoms in Chronic Painful Chemotherapy-Induced Peripheral Neuropathy. Pain Management Nursing, 19(4), 354–365. https://doi.org/10.1016/j.pmn.2018.01.001.
Latremoliere, A., & Woolf, C. J. (2009). Central Sensitization: A Generator of Pain Hypersensitivity by Central Neural Plasticity. The Journal of Pain, 10(9), 895–926. https://doi.org/https://doi.org/10.1016/j.jpain.2009.06.012.
Loprinzi, C. L. et al (2020). Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update. Journal of Clinical Oncology?: Official Journal of the American Society of Clinical Oncology, 38(28). https://doi.org/10.1200/JCO.20.01399.
Meltzer-Brody, S., Leserman, J., Zolnoun, D., Steege, J., Green, E., & Teich, A. (2007). Trauma and posttraumatic stress disorder in women with chronic pelvic pain. Obstetrics and Gynecology, 109(4), 902–908. https://doi.org/10.1097/01.AOG.0000258296.35538.88.
Nicol, A. L. et al (2016). The association between a history of lifetime traumatic events and pain severity, physical function, and affective distress in patients with chronic pain. The Journal of Pain, 17(12), 1334–1348. https://doi.org/10.1016/j.jpain.2016.09.003.
Park, S. B. et al (2013). Chemotherapy-Induced Peripheral Neurotoxicity: A Critical Analysis. CA Cancer Journal for Clinicians, 63(6), 419–437. https://doi.org/10.1002/caac.21204.
Seretny, M., Currie, G. L., Sena, E. S., Ramnarine, S., Grant, R., MacLeod, M. R., Colvin, L. A., & Fallon, M. (2014). Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis. Pain, 155(12), 2461–2470. https://doi.org/10.1016/j.pain.2014.09.020.
Smith, E.M.L. et al (2014). Cancer treatment-related neuropathic pain syndromes—epidemiology and treatment: An update. Current Pain and Headache Reports, 18(11). https://doi.org/10.1007/s11916-014-0459-7.
Smith, Ellen M Lavoie, et al (2013). Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy. JAMA, 309(13), 1359–1367.
Spinhoven, P. et al (2004). Catastrophizing and internal pain control as mediators of outcome in the multidisciplinary treatment of chronic low back pain. European Journal of Pain (London, England), 8(3), 211–219. https://doi.org/10.1016/j.ejpain.2003.08.00.
Wang, S.-Y., Calderon, J., & Kuo Wang, G. (2010). Block of neuronal Na+ channels by antidepressant duloxetine in a state-dependent manner. Anesthesiology, 113(3), 655–665. http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=med6&AN=2069387.
